You are here

Freeze Dried Plasma for Canines

Award Information
Agency: Department of Defense
Branch: Special Operations Command
Contract: H92222-18-C-0015
Agency Tracking Number: S2-0361
Amount: $1,499,744.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: SOCOM163-007
Solicitation Number: 2016.3
Timeline
Solicitation Year: 2016
Award Year: 2018
Award Start Date (Proposal Award Date): 2018-02-05
Award End Date (Contract End Date): 2019-08-02
Small Business Information
3185 Rampart Road, Fort Collins, CO, 80523
DUNS: 078823001
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Kelly Mann, DVM
 (970) 631-6917
 rod@manteltechnologies.com
Business Contact
 Michael Cushman
Phone: (508) 410-9230
Email: mc@manteltechnologies.com
Research Institution
N/A
Abstract
Hemorrhage is the leading cause of preventable death in combat, and damage control resuscitation (DCR) research has shown that plasma is a superior resuscitation fluid for severely injured, bleeding canine casualties.However, cold chain requirements make managing fresh frozen plasma (FFP) supply logistics difficult in austere environments.Limited supplies of pathogen reduced freeze-dried plasma (FDP) are currently available to the US military today through an agreement with the French Military for human use.However, there is no capability to provide Military Working Dogs (MWD) with any blood products. In this Phase II SBIR, Mantel Technologies proposes to continue the development of an FDP process and packaging solution for military working dogs and other canines. This effort will expand upon Phase I data to broaden repeatability, assess safety via a low risk study, and develop a user-focused canine FDP kit for field use.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government